Oligomerization and Multimerization Are Critical for Angiopoietin-1 to Bind and Phosphorylate Tie2
Open accessThe DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Abstract
Angiopoietin-1 (Ang1) is an essential molecule for blood vessel formation; however, little is known about the structure-function relationships of Ang1 with its receptor, Tie2 (tyrosine kinase with immunoglobulin and epidermal growth factor homology domain-2'). In this study, we generated several Ang1 and angiopoietin-2 (Ang2) variants to define the role of the superclustering and oligomerization domains of the Ang1 protein. Then we analyzed the molecular structure of the variants with SDS-PAGE and rotary metal-shadowing transmission electron microscopy (RMSTEM) and determined the effects of these variants on the binding and activation of Tie2. Ang1 exists as heterogeneous multimers with basic trimeric, tetrameric, and pentameric oligomers, whereas Ang2 exists as trimeric, tetrameric, and pentameric oligomers. The variant Ang1C265S, consisting of trimers, tetramers, and pentamers without multimeric forms of Ang1, yielded less Tie2 activation than did Ang1, whereas monomeric Ang1 (Ang1/FD), dimeric Ang1 variants (Ang1D2, and Ang1D3), and dimeric and trimeric Ang1 variant (Ang1D1) dramatically lost their ability to bind and activate Tie2. An Ang1 protein in which two cysteines (amino acids 41 and 54) were replaced with serines (Ang1C41S/C54S) formed mostly dimers and trimers that were not able to bind and activate Tie2. In addition, improper creation of a new cysteine in Ang2 (Ang2S263C) dramatically induced Ang2 aggregation without activating Tie2. In conclusion, proper oligomerization of Ang1 having at least four subunits by the intermolecular disulfide linkage involving cysteines 41 and 54 is critical for Tie2 binding and activation. Thus, our data shed a light on the structure-function relationships of Ang1 with Tie2.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The weaker TIE2 agonist activity of ANGPT2, in comparison with ANGPT1, has been attributed in part to its lower oligomeric forms (43, 59).”
From Inactive β1-integrin acts as a junctional scaffold for angiopoietin/TIE2/FOXO1 signaling (2026) · cites this paper as [43]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mechanisms of angiogenesis and arteriogenesis
Carmeliet, P. (2000) · Nature Medicine · doi:10.1038/74651 · Cited by 4,162
Vascular-specific growth factors and blood vessel formation
Yancopoulos, G. D., Davis, S., Gale, N. W., Rudge, J. S., Wiegand, S. J., & Holash, J. (2000) · Nature · doi:10.1038/35025215 · Cited by 3,699
Angiopoietin-2, a Natural Antagonist for Tie2 That Disrupts in vivo Angiogenesis
Maisonpierre, P. C., Suri, C., Jones, P. F., Bartunkova, S., Wiegand, S. J., Radziejewski, C., Compton, D., McClain, J., Aldrich, T. H., Papadopoulos, N., et al. (1997) · Science · doi:10.1126/science.277.5322.55 · Cited by 3,570
Requisite Role of Angiopoietin-1, a Ligand for the TIE2 Receptor, during Embryonic Angiogenesis
Suri, C., Jones, P. F., Patan, S., Bartunkova, S., Maisonpierre, P. C., Davis, S., Sato, T. N., & Yancopoulos, G. D. (1996) · Cell · doi:10.1016/s0092-8674(00)81813-9 · Cited by 2,847
Isolation of Angiopoietin-1, a Ligand for the TIE2 Receptor, by Secretion-Trap Expression Cloning
Davis, S., Aldrich, T. H., Jones, P. F., Acheson, A., Compton, D. L., Jain, V., Ryan, T. E., Bruno, J., Radziejewski, C., Maisonpierre, P. C., et al. (1996) · Cell · doi:10.1016/s0092-8674(00)81812-7 · Cited by 1,989
Leakage-Resistant Blood Vessels in Mice Transgenically Overexpressing Angiopoietin-1
Thurston, G., Suri, C., Smith, K., McClain, J., Sato, T. N., Yancopoulos, G. D., & McDonald, D. M. (1999) · Science · doi:10.1126/science.286.5449.2511 · Cited by 1,359
Angiopoietin-1 protects the adult vasculature against plasma leakage
Thurston, G., Rudge, J. S., Ioffe, E., Zhou, H., Ross, L., Croll, S. D., Glazer, N., Holash, J., McDonald, D. M., & Yancopoulos, G. D. (2000) · Nature Medicine · doi:10.1038/74725 · Cited by 1,297
Increased Vascularization in Mice Overexpressing Angiopoietin-1
Suri, C., McClain, J., Thurston, G., McDonald, D. M., Zhou, H., Oldmixon, E. H., Sato, T. N., & Yancopoulos, G. D. (1998) · Science · doi:10.1126/science.282.5388.468 · Cited by 818
Fiedler, U., Scharpfenecker, M., Koidl, S., Hegen, A., Grunow, V., Schmidt, J. M., Kriz, W., Thurston, G., & Augustin, H. G. (2004) · Blood · doi:10.1182/blood-2003-10-3685 · Cited by 742
Kim, I., Kim, H. G., So, J.-N., Kim, J. H., Kwak, H. J., & Koh, G. Y. (2000) · Circulation Research · doi:10.1161/01.res.86.1.24 · Cited by 649
Self-citation
Cited by
Control of vascular morphogenesis and homeostasis through the angiopoietin–Tie system
Augustin, H. G., Young Koh, G., Thurston, G., & Alitalo, K. (2009) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2639 · Cited by 1,465
“Electron microscopic rotary shadowing experiments on Ang proteins show heterogeneous multimers with trimeric, tetrameric and pentameric oligomers for both ANG1 and ANG2 (Ref”
BackgroundSelf-citationCellular and Molecular Basis of Pulmonary Arterial Hypertension
Morrell, N. W., Adnot, S., Archer, S. L., Dupuis, J., Lloyd Jones, P., MacLean, M. R., McMurtry, I. F., Stenmark, K. R., Thistlethwaite, P. A., Weissmann, N., et al. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.04.018 · Cited by 819
“Angiopoietin and TIE2.”
InfluentialFagiani, E., & Christofori, G. (2013) · Cancer Letters · doi:10.1016/j.canlet.2012.08.018 · Cited by 676
Therapeutic targeting of the angiopoietin–TIE pathway
Saharinen, P., Eklund, L., & Alitalo, K. (2017) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2016.278 · Cited by 620
Signaling and Functions of Angiopoietin-1 in Vascular Protection
Brindle, N. P. J., Saharinen, P., & Alitalo, K. (2006) · Circulation Research · doi:10.1161/01.res.0000218275.54089.12 · Cited by 487
Targeting the ANGPT–TIE2 pathway in malignancy
Huang, H., Bhat, A., Woodnutt, G., & Lappe, R. (2010) · Nature Reviews Cancer · doi:10.1038/nrc2894 · Cited by 468
“However, owing to the multimeric nature of ANGPT1 and ANGPT2, it has been proposed that TIE2 receptors might also function as multimer”
BackgroundSaharinen, P., Eklund, L., Miettinen, J., Wirkkala, R., Anisimov, A., Winderlich, M., Nottebaum, A., Vestweber, D., Deutsch, U., Koh, G. Y., et al. (2008) · Nature Cell Biology · doi:10.1038/ncb1715 · Cited by 471
Self-citationTumor Development and Angiogenesis in Adult Brain Tumor: Glioblastoma
Ahir, B. K., Engelhard, H. H., & Lakka, S. S. (2020) · Molecular Neurobiology · doi:10.1007/s12035-020-01892-8 · Cited by 424
The role of the Angiopoietins in vascular morphogenesis
Thomas, M., & Augustin, H. G. (2009) · Angiogenesis · doi:10.1007/s10456-009-9147-3 · Cited by 405
“ogeneous multimers with trimers, tetramers and pentamers [6].”
Angiopoietin 2 Is a Partial Agonist/Antagonist of Tie2 Signaling in the Endothelium
Yuan, H. T., Khankin, E. V., Karumanchi, S. A., & Parikh, S. M. (2009) · Molecular and Cellular Biology · doi:10.1128/mcb.01472-08 · Cited by 373
“The multimerization of Ang1 may account for its ability to strongly activate Tie2 (25).”
BackgroundSignaling pathways and intervention therapies in sepsis
Zhang, Y.-Y., & Ning, B.-T. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00816-9 · Cited by 349
Plastic roles of pericytes in the blood–retinal barrier
Park, D. Y., Lee, J., Kim, J., Kim, K., Hong, S., Han, S., Kubota, Y., Augustin, H. G., Ding, L., Kim, J. W., et al. (2017) · Nature Communications · doi:10.1038/ncomms15296 · Cited by 322
Self-citationMutation of the angiopoietin-1 gene (ANGPT1) associates with a new type of hereditary angioedema
Bafunno, V., Firinu, D., D'Apolito, M., Cordisco, G., Loffredo, S., Leccese, A., Bova, M., Barca, M. P., Santacroce, R., Cicardi, M., et al. (2018) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2017.05.020 · Cited by 308
Pathophysiology of the Diabetic Kidney
Vallon, V., & Komers, R. (2011) · Comprehensive Physiology · doi:10.1002/cphy.c100049 · Cited by 259
Amelioration of sepsis by TIE2 activation–induced vascular protection
Han, S., Lee, S.-J., Kim, K. E., Lee, H. S., Oh, N., Park, I., Ko, E., Oh, S. J., Lee, Y.-S., Kim, D., et al. (2016) · Science Translational Medicine · doi:10.1126/scitranslmed.aad9260 · Cited by 203
Self-citationOrchestral actions of angiopoietin-1 in vascular regeneration
Koh, G. Y. (2013) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2012.10.010 · Cited by 183
Self-citationReceptor Tyrosine Kinase-Mediated Angiogenesis
Jeltsch, M., Leppanen, V.-M., Saharinen, P., & Alitalo, K. (2013) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a009183 · Cited by 175
“The angiopoietins comprise a structurally unique family of growth factor ligands that multimerize to form various-sized multimers with multiple receptor-binding domains (Kim et al. 2005).”
BackgroundAngiopoietin-1 is required for Schlemm’s canal development in mice and humans
Thomson, B. R., Souma, T., Tompson, S. W., Onay, T., Kizhatil, K., Siggs, O. M., Feng, L., Whisenhunt, K. N., Yanovitch, T. L., Kalaydjieva, L., et al. (2017) · Journal of Clinical Investigation · doi:10.1172/jci95545 · Cited by 171
Bench-to-bedside review: Angiopoietin signalling in critical illness – a future target?
van Meurs, M., Kümpers, P., Ligtenberg, J. J. M., Meertens, J. H. J. M., Molema, G., & Zijlstra, J. G. (2009) · Critical Care · doi:10.1186/cc7153 · Cited by 163
Angiopoietin-like proteins: potential new targets for metabolic syndrome therapy
Oike, Y., Akao, M., Kubota, Y., & Suda, T. (2005) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2005.08.002 · Cited by 155
Smooth Muscle Cell Hypertrophy, Proliferation, Migration and Apoptosis in Pulmonary Hypertension
Tajsic, T., & Morrell, N. W. (2010) · Comprehensive physiology · doi:10.1002/cphy.c100026 · Cited by 169
Context-dependent functions of angiopoietin 2 are determined by the endothelial phosphatase VEPTP
Souma, T., Thomson, B. R., Heinen, S., Anna Carota, I., Yamaguchi, S., Onay, T., Liu, P., Ghosh, A. K., Li, C., Eremina, V., et al. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1714446115 · Cited by 135
“Although ANGPT2 can form high-order oligomers, it is primarily observed as a dimer (49).”
BackgroundCrystal structures of the Tie2 receptor ectodomain and the angiopoietin-2–Tie2 complex
Barton, W. A., Tzvetkova-Robev, D., Miranda, E. P., Kolev, M. V., Rajashankar, K. R., Himanen, J. P., & Nikolov, D. B. (2006) · Nature Structural & Molecular Biology · doi:10.1038/nsmb1101 · Cited by 134
“Indeed, all angiopoietins exist primarily as tetramers, hexamers and higher-order oligomers in solutio”
BackgroundSignaling pathways in the development of infantile hemangioma
Ji, Y., Chen, S., Li, K., Li, L., Xu, C., & Xiang, B. (2014) · Journal of Hematology & Oncology · doi:10.1186/1756-8722-7-13 · Cited by 146
“Only tetrameric or higher multimeric forms of Ang-1 activate Tie-2, whereas oligomeric Ang-2 is a weak context-dependent agonist of Tie-2 and may even antagonize the receptor [99].”
BackgroundStructural basis of Tie2 activation and Tie2/Tie1 heterodimerization
Leppänen, V.-M., Saharinen, P., & Alitalo, K. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1616166114 · Cited by 127
“Because multimerization of Ang1 and Ang2 is critical for Tie2 phosphorylation, it has been suggested that the difference between the agonistic activities of Ang1 and Ang2 is caused by different oligomeric states (34, 35).”
BackgroundInfluentialRoles of Angiopoietins in Kidney Development and Disease
Woolf, A. S., Gnudi, L., & Long, D. A. (2008) · Journal of the American Society of Nephrology · doi:10.1681/asn.2008020243 · Cited by 122
Oudega, M. (2012) · Cell and Tissue Research · doi:10.1007/s00441-012-1440-6 · Cited by 134
“Ang2 is seen as a natural inhibitor of the BBBstabilizing Ang1 as it competitively inhibits Ang1/Tie-2 effects (Maisonpierre et al. 1997; Makinde and Agrawal 2008).”
BackgroundInfluentialLymphangiogenesis requires Ang2/Tie/PI3K signaling for VEGFR3 cell-surface expression
Korhonen, E. A., Murtomäki, A., Jha, S. K., Anisimov, A., Pink, A., Zhang, Y., Stritt, S., Liaqat, I., Stanczuk, L., Alderfer, L., et al. (2022) · Journal of Clinical Investigation · doi:10.1172/jci155478 · Cited by 113
The angiopoietin-Tie2 signaling axis in the vascular leakage of systemic inflammation
Milam, K. E., & Parikh, S. M. (2014) · Tissue Barriers · doi:10.4161/21688362.2014.957508 · Cited by 116
Dysregulation of the angiopoietin–Tie-2 axis in sepsis and ARDS
Parikh, S. M. (2013) · Virulence · doi:10.4161/viru.24906 · Cited by 112
Moss, A. (2013) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2013.05.009 · Cited by 113
“monomers assembles in a tetrameric conformation being required to stimulate the tyrosine kinase domains [6].”
BackgroundInfluentialEffects of a synthetic PEG-ylated Tie-2 agonist peptide on endotoxemic lung injury and mortality
David, S., Ghosh, C. C., Kümpers, P., Shushakova, N., Van Slyke, P., Khankin, E. V., Karumanchi, S. A., Dumont, D., & Parikh, S. M. (2011) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00459.2010 · Cited by 96
“Since domain-swap and point mutant experiments had already established the importance of clustering Tie-2 monomers for efficient signal transduction through the receptor (12, 23), a cysteine residue was attached to the NH2 terminus of the above 7-mer to covalently tether these monomers to a polyethylene glycol (PEG) b…”
BackgroundVascular endothelial growth factors in cardiovascular medicine
Testa, U., Pannitteri, G., & Condorelli, G. (2008) · Journal of Cardiovascular Medicine · doi:10.2459/jcm.0b013e3283117d37 · Cited by 95
The Angiopoietin-Tie2 Signaling Axis in Systemic Inflammation
Parikh, S. M. (2017) · Journal of the American Society of Nephrology · doi:10.1681/asn.2017010069 · Cited by 99
Vascular Disruption and the Role of Angiogenic Proteins After Spinal Cord Injury
Ng, M., Stammers, A. T., & Kwon, B. K. (2011) · Translational Stroke Research · doi:10.1007/s12975-011-0109-x · Cited by 94
“Receptor tyrosine kinases such as Tie2 have been reported to require multimerization for receptor activation [113, 155].”
BackgroundLukasz, A. H., Hellpap, J., Horn, R., Kielstein, J. T., David, S., Haller, H. G., & Kümpers, P. (2008) · Critical Care · doi:10.1186/cc6966 · Cited by 87
“A molecular weight >55 kDa makes angiopoietins unlikely participants for dialytic clearance [34].”
BackgroundMakinde, T., & Agrawal, D. K. (2008) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2008.00254.x · Cited by 79
“Ang-1 can exist as a 70 kD glycoprotein and Ang2 as a 62–70 kD glycoprotein under reduced condition [48].”
BackgroundInfluentialThe Tie2 signaling pathway in retinal vascular diseases: a novel therapeutic target in the eye
Nguyen, Q. D., Heier, J. S., Diana, V., Mirando, A. C., Pandey, N. B., Sheng, H., & Heah, T. (2020) · International Journal of Retina and Vitreous · doi:10.1186/s40942-020-00250-z · Cited by 80
Hematopoietic versus leukemic stem cell quiescence: Challenges and therapeutic opportunities
O’Reilly, E., Zeinabad, H. A., & Szegezdi, É. (2021) · Blood Reviews · doi:10.1016/j.blre.2021.100850 · Cited by 87
Kim, K., SHIN, I., KIM, J., CHOI, J., Byun, J., JEON, E., Suh, W., & Kim, D.-H. (2006) · Cardiovascular Research · doi:10.1016/j.cardiores.2006.08.002 · Cited by 89
“In particular, it is presumed that the Tie2 receptor should be multimerized for its activation, as with other receptor tyrosine kinases, so that the higher expression level of Tie2 is more likely to facilitate receptor multimerization and subsequent phosphorylation at the same concentration of ligand [21,22].”
BackgroundSelf-citationAngiopoietins and diabetic nephropathy
Gnudi, L. (2016) · Diabetologia · doi:10.1007/s00125-016-3995-3 · Cited by 74
“ANGPT1 is the major physiological ligand and activator (via phosphorylation) of the TIE-2 receptor [11, 12].”
BackgroundMolecular Regulation of Sprouting Angiogenesis
Duran, C. L., Howell, D. W., Dave, J. M., Smith, R. L., Torrie, M. E., Essner, J. J., & Bayless, K. J. (2017) · Comprehensive physiology · doi:10.1002/cphy.c160048 · Cited by 86
The Angiopoietin-Tie2 Pathway in Critical Illness
Sack, K. D., Kellum, J. A., & Parikh, S. M. (2020) · Critical Care Clinics · doi:10.1016/j.ccc.2019.12.003 · Cited by 77
Jeong, B., Kim, H., Bae, I., Lee, K.-N., Lee, K.-Y., Oh, W., Kim, S.-H., Kang, I., Lee, S.-E., Koh, G.-Y., et al. (2009) · Bone · doi:10.1016/j.bone.2009.09.019 · Cited by 67
Self-citationAngiopoietin-4 Promotes Glioblastoma Progression by Enhancing Tumor Cell Viability and Angiogenesis
Brunckhorst, M. K., Wang, H., Lu, R., & Yu, Q. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-4125 · Cited by 75
Angiopoietin-Tie Signaling Pathway in Endothelial Cells: A Computational Model
Zhang, Y., Kontos, C. D., Annex, B. H., & Popel, A. S. (2019) · iScience · doi:10.1016/j.isci.2019.10.006 · Cited by 74
Thomson, B. R., Carota, I. A., Souma, T., Soman, S., Vestweber, D., & Quaggin, S. E. (2019) · eLife · doi:10.7554/elife.48474 · Cited by 63
“Activation of the TEK receptor has been achieved in vitro and in vivo either by increasing activity of endogenous ANGPT ligands, providing ANGPT recombinant proteins (Kim et al., 2005; Souma et al., 2018), or by suppression of the phosphatase PTPRB (also known as the Vascular Endothelial Protein Tyrosine Phosphatase,…”
BackgroundSchlosser, A., Thomsen, T. C., Shipley, J. M., Hein, P. W., Brasch, F. E., Tornøe, I., Nielsen, O., Skjødt, K., Palaniyar, N., Steinhilber, W., et al. (2006) · Scandinavian Journal of Immunology · doi:10.1111/j.1365-3083.2006.01778.x · Cited by 63
Anisimov, A., Tvorogov, D., Alitalo, A. K., Leppänen, V., An, Y., Han, E. C., Orsenigo, F., Gaál, E. I., Holopainen, T., Koh, Y. J., et al. (2013) · Circulation · doi:10.1161/circulationaha.112.127472 · Cited by 61
“The schematic structures of the VEGF and Ang1 subunit polypeptide chains and of the VEGF-Ang1 chimera are shown in Figure 1A.(18) Mature VEGF is an antiparallel homodimer”
MethodSelf-citationImpaired function of the Tie-2 receptor contributes to vascular leakage and lethality in anthrax
Ghosh, C. C., Mukherjee, A., David, S., Knaus, U. G., Stearns-Kurosawa, D. J., Kurosawa, S., & Parikh, S. M. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1120755109 · Cited by 60
A collagen IV–derived peptide disrupts α5β1 integrin and potentiates Ang2/Tie2 signaling
Mirando, A. C., Shen, J., Silva, R. L. E., Chu, Z., Sass, N. C., Lorenc, V. E., Green, J. J., Campochiaro, P. A., Popel, A. S., & Pandey, N. B. (2019) · JCI Insight · doi:10.1172/jci.insight.122043 · Cited by 57
Systems biology of angiogenesis signaling: Computational models and omics
Zhang, Y., Wang, H., Oliveira, R. H. D. M., Zhao, C., & Popel, A. S. (2021) · WIREs Mechanisms of Disease · doi:10.1002/wsbm.1550 · Cited by 60
Yang, Z., Xia, W., Zhang, Y., Xu, S., Liu, X., Zhang, X., Yu, B., Qiu, Y., & Tao, J. Y. (2012) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2012.01.019 · Cited by 52
“It was reported that ligand-induced Tie2 multimerization is critical for Tie2 binding and phosphorylation [37,38].”
BackgroundKołodziejczyk-Czepas, J., & Ponczek, M. B. (2013) · Współczesna Onkologia · doi:10.5114/wo.2013.34611 · Cited by 51
“Since Ang-1 mediates the maturation of blood vessels, this activity may have therapeutic significance in the specific inhibition of tumor vascularization [41].”
BackgroundKhan, K. A., Wu, F. T. H., Cruz‐Muñoz, W., & Kerbel, R. S. (2021) · EMBO Molecular Medicine · doi:10.15252/emmm.201708253 · Cited by 56
Characterization of ANGPT2 mutations associated with primary lymphedema
Leppänen, V.-M., Brouillard, P., Korhonen, E. A., Sipilä, T., Jha, S. K., Revencu, N., Labarque, V., Fastré, E., Schlögel, M., Ravoet, M., et al. (2020) · Science Translational Medicine · doi:10.1126/scitranslmed.aax8013 · Cited by 49
Self-citationRegulation of Angiopoietin Signalling by Soluble Tie2 Ectodomain and Engineered Ligand Trap
Alawo, D. O. A., Tahir, T. A., Fischer, M., Bates, D. G., Amirova, S. R., & Brindle, N. P. J. (2017) · Scientific Reports · doi:10.1038/s41598-017-03981-6 · Cited by 50
Shroff, R. C., Price, K. L., Kolatsi‐Joannou, M., Todd, A. F., Wells, D., Deanfield, J. E., Johnson, R. J., Rees, L., Woolf, A. S., & Long, D. A. (2013) · PLoS ONE · doi:10.1371/journal.pone.0056273 · Cited by 56
“[11] As such, Ang-1 is usually considered beneficial for endothelial cell function.”
BackgroundOsteoblast-specific Angiopoietin 1 overexpression increases bone mass
Suzuki, T., Miyamoto, T. K., Fujita, N., Ninomiya, K., Iwasaki, R., Toyama, Y., & Suda, T. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.08.099 · Cited by 51
Zheng, X., Koh, G. Y., & Jackson, T. L. (2013) · Discrete and Continuous Dynamical Systems - B · doi:10.3934/dcdsb.2013.18.1109 · Cited by 51
“64× 10μM given the molecular weight ∼ 70 Kda for both Ang1 and Ang2 [75].”
BackgroundSelf-citationvan der Heijden, M., Amerongen, G. P. V. N., van Bezu, J. S. M., Paul, M. A., Groeneveld, A. B. J., & van Hinsbergh, V. W. M. (2011) · PLoS ONE · doi:10.1371/journal.pone.0023448 · Cited by 50
“[43] bridge Tie-2 receptors of both adjacent cells [41,44].”
BackgroundMolecular control of angiopoietin signalling
Singh, H., Tahir, T. A., Alawo, D. O. A., Issa, E., & Brindle, N. P. J. (2011) · Biochemical Society Transactions · doi:10.1042/bst20110699 · Cited by 43
Integrin binding angiopoietin‐1 monomers reduce cardiac hypertrophy
Dallabrida, S. M., Ismail, N. S., Pravda, E. A., Parodi, E. M., Dickie, R., Durand, E. M., Lai, J., Cassiola, F. M., Rogers, R. A., & Rupnick, M. A. (2008) · The FASEB Journal · doi:10.1096/fj.07-100966 · Cited by 50
Vascular growth factors play critical roles in kidney glomeruli
Gnudi, L., Benedetti, S., Woolf, A. S., & Long, D. A. (2015) · Clinical Science · doi:10.1042/cs20150403 · Cited by 46
Targeting angiogenesis in cancer therapy.
Ichihara, E., Kiura, K., & Tanimoto, M. (2011) · Institutional Repositories DataBase (IRDB) · doi:10.18926/amo/47260 · Cited by 49
“Many tyrosine kinase receptors form dimerization during ligands binding, but Tie2 forms dimerization or multimerization on Ang-1/Ang-2 binding [36].”
BackgroundWu, F. T., Lee, C. R., Bogdanovic, E., Prodeus, A., Gariépy, J., & Kerbel, R. S. (2015) · EMBO Molecular Medicine · doi:10.15252/emmm.201404193 · Cited by 38
“Their monomeric structures are highly similar, but Ang1 predominantly exists in higher-order multimeric forms, while Ang2 mainly exists in dimeric form (Davis et al , 2003; Cho et al , 2004; Kim et al , 2005).”
F-domain valency determines outcome of signaling through the angiopoietin pathway
Zhao, Y. T., Fallas, J. A., Saini, S., Ueda, G., Somasundaram, L., Zhou, Z., Raj, I. X., Ehnes, D. D., Xu, C., Carter, L. P., et al. (2021) · EMBO Reports · doi:10.15252/embr.202153471 · Cited by 39
“As noted earlier, because the native ligands Ang1 and Ang2 populate multiple oligomerization states (Kim et al , 2000b, 2005; Davis et al , 2003), delineating the role of valency has been difficult.”
Weeraratne, D. K., Lofgren, J. A., Dinnogen, S., Swanson, S. J., & Zhong, Z. D. (2013) · Journal of Immunological Methods · doi:10.1016/j.jim.2013.07.010 · Cited by 37
“Multimerization in vivo is required to initiate binding to the Tie2 receptor and subsequent downstream signaling (Davis et al., 2003; Kim et al., 2005; Barton et al., 2006).”
BackgroundThe Angiopoietin ligands and Tie receptors: potential diagnostic biomarkers of vascular disease
Bilimoria, J., & Singh, H. (2019) · Journal of Receptors and Signal Transduction · doi:10.1080/10799893.2019.1652650 · Cited by 39
“The functional roles of Angpt1 arise from the binding of the ligand, in tetramer form or higher, to the Tie2 homodimer complex [11,12].”
BackgroundEndothelial Progenitor Cells in the Host Defense Response
Shi, X., Seidle, K. A., Simms, K. J., Dong, F., Chilian, W. M., & Zhang, P. (2022) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2022.108315 · Cited by 44
Sha, L., Zhao, Y., Li, S., Wei, D., Tao, Y., & Wang, Y. (2024) · Journal of Translational Medicine · doi:10.1186/s12967-024-05441-y · Cited by 43
“Native Ang1 exists in a highly oligomeric form, usually forming a tetramer or higher-order multi-meric structure [103].”
BackgroundInfluentialSignaling Network Map of Endothelial TEK Tyrosine Kinase
Khan, A. A., Sandhya, V. K., Singh, P., Parthasarathy, D., Kumar, A., Advani, J., Gattu, R., Ranjit, D. V., Vaidyanathan, R., Mathur, P. P., et al. (2014) · Journal of Signal Transduction · doi:10.1155/2014/173026 · Cited by 39
“Binding of ANGPT1 to TIE2 leads to receptor dimerization and subsequent activation followed by autophosphorylation at specific tyrosine residues [15, 17].”
BackgroundAngiopoietin 2 in placentation and tumor biology: The yin and yang of vascular biology
Wang, Q., & Lash, G. E. (2017) · Placenta · doi:10.1016/j.placenta.2017.03.021 · Cited by 38
Beyond VEGF: Angiopoietin–Tie Signaling Pathway in Diabetic Retinopathy
Chen-Li, G., Martinez-Archer, R., Brenes, A. C., Roca, J. A., Rodríguez, F. J., Acaba-Berrocal, L. A., Berrocal, M. H., & Wu, L. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13102778 · Cited by 39
“As Ang1 is secreted, it predominantly exists as higher-order multimers [32,39].”
BackgroundThe Role of Angiopoietins in Neovascular Diabetes-Related Retinal Diseases
Collazos-Alemán, J. D., Gnecco-González, S., Jaramillo-Zarama, B., Jiménez-Mora, M. A., & Mendivil, C. O. (2022) · Diabetes Therapy · doi:10.1007/s13300-022-01326-9 · Cited by 35
“Only tetrameric or higher multimeric forms of Ang1 induce Tie2 phosphorylation, and in fact, the majority of Ang1 molecules exist in trimeric, tetrameric, and pentameric forms [4].”
BackgroundOh, N., Kim, K., Kim, S. J., Park, I., Lee, J. J., Seo, Y. S., An, H. J., Kim, H. M., & Koh, G. Y. (2015) · Scientific Reports · doi:10.1038/srep15291 · Cited by 34
Self-citationDimerization of Tie2 mediated by its membrane-proximal FNIII domains
Moore, J. O., Lemmon, M. A., & Ferguson, K. M. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1617800114 · Cited by 30
“The clustering model, together with the requirement for oligomeric ligands (14, 41), suggests similarities with the extended signaling arrays of Eph family receptors thought to be “seeded” by extracellular interactions (33, 34, 42).”
BackgroundKim, H.-Z., Jung, K., Kim, H. M., Cheng, Y., & Koh, G. Y. (2009) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2009.01.018 · Cited by 39
Self-citationA new era of disease modeling and drug discovery using induced pluripotent stem cells
Suh, W. (2016) · Archives of Pharmacal Research · doi:10.1007/s12272-016-0871-0 · Cited by 34
The role of Ang/Tie signaling in lymphangiogenesis.
Wu, X., & Liu, N. (2010) · PubMed · Cited by 34
Targeting angiogenesis in gliomas: Potential role of phytochemicals
Sanati, M., Afshari, A. R., Amini, J., Mollazadeh, H., Jamialahmadi, T., & Sahebkar, A. (2022) · Journal of Functional Foods · doi:10.1016/j.jff.2022.105192 · Cited by 31
The Dynamic roles of Angiopoietins in Tumor Angiogenesis
Yu, Q. (2005) · Future Oncology · doi:10.2217/14796694.1.4.475 · Cited by 36
Anti-angiogenic Targets: Angiopoietin and Angiopoietin Receptors
Kiss, E. A., & Saharinen, P. (2019) · Springer eBooks · doi:10.1007/978-3-319-33673-2_4 · Cited by 32
Pietilä, R. S., Nätynki, M., Tammela, T., Kangas, J., Pulkki, K. H., Limaye, N., Vikkula, M., Koh, G. Y., Saharinen, P., Alitalo, K. K., et al. (2012) · Journal of Cell Science · doi:10.1242/jcs.098020 · Cited by 34
“In this analysis, 50–55% of the Ang1 molecules formed large-sized multimers, whereas only 10–20% of Ang2 molecules were multimers (Kim et al., 2005).”
BackgroundInfluentialSelf-citationJo, G., Bae, J., Hong, H. J., Han, A. R., Kim, D.-K., Hong, S. P., Kim, J. A., Lee, S., Koh, G. Y., & Kim, H. M. (2021) · Nature Communications · doi:10.1038/s41467-021-26620-1 · Cited by 32
Self-citationStatz, S., Sabal, G., Walborn, A., Williams, M. D., Hoppensteadt, D., Mosier, M. M., Rondina, M. T., & Fareed, J. (2018) · Clinical and Applied Thrombosis/Hemostasis · doi:10.1177/1076029618786029 · Cited by 31
“9 – Median (range) 79 (14-150) 73 (14-150) 107.”
Milner, C. S., Hansen, T. M., Singh, H., & Brindle, N. P. J. (2008) · Microvascular Research · doi:10.1016/j.mvr.2008.09.003 · Cited by 36
Angiogenesis and autosomal dominant polycystic kidney disease
Huang, J. L., Woolf, A. S., & Long, D. A. (2012) · Pediatric Nephrology · doi:10.1007/s00467-012-2305-7 · Cited by 25
“Ang binds to Tie2 (tyrosine kinase with Ig and EGF homology domain 2), with Ang-1 oligomers and multimers binding to and tyrosine-phosphorylating Tie2 through their carboxylic acid (COOH)-terminal fibrinogen-like domains, leading to endothelial survival and stabilization [22].”
BackgroundKorpela, E., Yohan, D., Chin, L. C. L., Kim, A., Huang, X., Sade, S., Slyke, P. V., Dumont, D., & Liu, S. K. (2014) · BMC Cancer · doi:10.1186/1471-2407-14-614 · Cited by 29
“Ang1 variants, such as a pentameric cartilage oligomeric matrix protein (COMP-) Ang1 [30], are often utilized in lieu of the endogenous protein due to Ang1 multimer instability [31].”
BackgroundChiang, W., Huang, Y.-C., Fu, T.-I., Chen, P.-M., Chang, F., Lai, C., Wu, V., Lin, S., & Chen, Y. (2019) · Molecular Medicine · doi:10.1186/s10020-019-0072-7 · Cited by 30
Loreth, D., Sachs, W., & Meyer‐Schwesinger, C. (2025) · Acta Physiologica · doi:10.1111/apha.70081 · Cited by 32
Role of Endotoxemia in Causing Renal Dysfunction in Cirrhosis
Peng, J. L., Techasatian, W., Hato, T., & Liangpunsakul, S. (2020) · Journal of Investigative Medicine · doi:10.1136/jim-2019-001056 · Cited by 27
Cao, L., Liu, X., Liu, S., Jiang, Y., Zhang, X., Zhang, C., & Zeng, B. (2012) · Journal of Biomedical Materials Research Part B Applied Biomaterials · doi:10.1002/jbm.b.32687 · Cited by 23
Hwang, S.-J., Yoon, S. K., Koh, G. Y., & Lee, G. M. (2011) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-011-3266-7 · Cited by 29
“However, the unique structure of Ang1 causes aggregation and insolubility of the protein and thereby hinders high-level expression of recombinant Ang1 from Chinese hamster ovary (CHO) cells (Cho et al. 2004; Davis et al. 2003; Kim et al. 2005).”
BackgroundSelf-citationAngiopoietin-4 increases permeability of blood vessels and promotes lymphatic dilation
Kesler, C. T., Pereira, E. R., Cui, C. H., Nelson, G. M., Masuck, D. J., Baish, J. W., & Padera, T. P. (2015) · The FASEB Journal · doi:10.1096/fj.14-268920 · Cited by 31
“ANGs are secreted proteins that bind their targets as multimeric clusters (1).”
Backgroundde Vega, S., Kondo, A., Suzuki, M., Arai, H., Jiapaer, S., Sabit, H., Nakada, M., Ikeuchi, T., Ishijima, M., Arikawa‐Hirasawa, E., et al. (2019) · International Journal of Cancer · doi:10.1002/ijc.32306 · Cited by 24
“One of the most interesting findings in the present study is that Fbln7 selectively binds to Ang1, but not to Ang2 or Tie2.”
BackgroundInfluentialWehrle, C., Slyke, P. V., & Dumont, D. (2009) · Biochemical Journal · doi:10.1042/bj20091010 · Cited by 20
Angiopoietins: vascular growth factors looking for roles in glomeruli
Woolf, A. S. (2009) · Current Opinion in Nephrology & Hypertension · doi:10.1097/mnh.0b013e328333025e · Cited by 20
Oligomerized Tie2 localizes to clathrin-coated pits in response to angiopoietin-1
Bogdanovic, E., Coombs, N. A., & Dumont, D. (2009) · Histochemistry and Cell Biology · doi:10.1007/s00418-009-0603-3 · Cited by 25
“Protein electrophoresis and structural studies have shown that Ang1, the ligand for Tie2, exists in variably sized homo-oligomeric complexes (trimers, tetramers, pentamers, and higher order clusters) ( Kim et al. 2005; Procopio et al. 1999).”
BackgroundInfluentialTse, K., Kingham, P. J., Novikov, L. N., & Wiberg, M. (2011) · Journal of Tissue Engineering and Regenerative Medicine · doi:10.1002/term.452 · Cited by 19
“This difference could be attributed to dynamic glycosylation for the multimeric regulation of Tie2 activation (Kim et al., 2005).”
Background
Metadata
- Authors
- Kim, K.-T., Choi, H.-H., Steinmetz, M. O., Maco, B., Kammerer, R. A., Ahn, S. Y., Kim, H.-Z., Lee, G. M., & Koh, G. Y.
- Affiliations
- Korea Advanced Institute of Science and Technology (KR)
- Paul Scherrer Institute (CH)
- University of Basel (CH)
- Wellcome Centre for Cell-Matrix Research (GB)
- Corresponding author
- Koh, Gou Young
- ORCID
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2005-05
- Volume
- 280
- Issue
- 20
- Pages
- 20126-20131
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2016078651
- Cited by
- 170
- References
- 32
- Citations by year
- 2026: 4 · 2025: 6 · 2024: 3 · 2023: 3 · 2022: 5 · 2021: 11 · 2020: 10 · 2019: 9 · 2018: 8 · 2017: 15 · 2016: 3 · 2015: 9 · 2014: 7 · 2013: 13 · 2012: 10
- FWCI
- 2.38
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor, 5641 d)
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DORA PSI (Paul Scherrer Institute) (submittedVersion, cc-by)
- Research Explorer (The University of Manchester) (submittedVersion)
- Funders
- Wellcome Trust
- Korea Science and Engineering Foundation
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
- Health Sciences › Medicine › Immunology and Allergy › Cell Adhesion Molecules Research
- Health Sciences › Medicine › Oncology › Lymphatic System and Diseases
- Keywords
- angiopoietin-1, angiopoietin-2, Tie2 receptor, receptor oligomerization, receptor multimerization, disulfide bonds, cysteine residues, receptor activation, receptor binding, angiogenesis, structure-function relationship, protein aggregation
- MeSH terms
- Animals, Cell Line, Cysteine, Enzyme Activation, Humans, Microscopy, Electron, Phosphorylation, Protein Binding, Recombinant Proteins, Genetic Variation, Protein Structure, Quaternary, 3T3-L1 Cells, Angiopoietin-1, Angiopoietin-2, Receptor, TIE-2, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.